HFCAS OpenIR
Knockdown of RRM1 in tumor cells promotes radio-/chemotherapy induced ferroptosis by regulating p53 ubiquitination and p21-GPX4 signaling axis
Gao, Yang1,2,3; Chen, Bin1,2; Wang, Ruru1,2; Xu, An1,2; Wu, Lijun4,5; Lu, Huayi6; Zhao, Guoping1,2
2022-08-01
发表期刊CELL DEATH DISCOVERY
通讯作者Lu, Huayi(Lhy510@jlu.edu.cn) ; Zhao, Guoping(gpz@ipp.ac.cn)
摘要Ferroptosis, a type of regulated cell death brought about by lipid peroxidation, has been discovered to suppress tumor growth. Here, we report that targeting RRM1 promotes ferroptosis and affects sensitivity to radiation and chemotherapeutics in cancer cells. In vitro experiments demonstrate that RRM1 increases the accumulation of cellular reactive oxygen species (ROS) and lipid peroxidation by disrupting the activity and expression of the antioxidant enzyme GPX4. Further studies reveal the downstream mechanisms of RRM1, which can regulate the deubiquitinating enzyme USP11 and ubiquitinating enzyme MDM2 to affect the ubiquitination modification of p53. Unstable p53 then inhibited the activity and expression of GPX4 by restraining the p21 protein. Furthermore, our data reveal that targeting RRM1 also increases radiation-induced DNA damage and apoptotic signaling and causes crosstalk between ferroptosis and apoptosis. On the basis of our collective findings, we propose that RRM1 is an essential negative mediator of radiosensitivity through regulating ferroptosis, which could serve as a potential target to inhibit the tumor's antioxidant system and enhance the efficiency of radio/chemotherapy.
DOI10.1038/s41420-022-01140-z
关键词[WOS]RIBONUCLEOTIDE REDUCTASE ; CANCER ; RADIORESISTANCE ; SUPPRESSION ; NETWORKS ; SUBUNIT ; BIOLOGY ; DEATH
收录类别SCI
语种英语
资助项目National Science Fund for Excellent Young Scholars[12122510] ; National Natural Science Foundation of China[32171240] ; National Natural Science Foundation of China[31870845] ; National Natural Science Foundation of China[11835014] ; Anhui Provincial Key RD Program[202104a07020006] ; HFIPS Director's Fund[BJPY2021B07] ; HFIPS Director's Fund[YZJJZX202014]
项目资助者National Science Fund for Excellent Young Scholars ; National Natural Science Foundation of China ; Anhui Provincial Key RD Program ; HFIPS Director's Fund
WOS研究方向Cell Biology
WOS类目Cell Biology
WOS记录号WOS:000834811500002
出版者SPRINGERNATURE
引用统计
被引频次:13[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.hfcas.ac.cn:8080/handle/334002/132210
专题中国科学院合肥物质科学研究院
通讯作者Lu, Huayi; Zhao, Guoping
作者单位1.Chinese Acad Sci, Key Lab High Magnet Field & Ion Beam Phys Biol, High Magnet Field Lab, Hefei, Anhui, Peoples R China
2.Chinese Acad Sci, Hefei Inst Phys Sci, Anhui Prov Key Lab Environm Toxicol & Pollut Cont, Hefei, Anhui, Peoples R China
3.Shantou Univ, Med Coll, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Guangdong, Peoples R China
4.Anhui Univ, Inst Phys Sci, Informat Mat & Intelligent Sensing Lab Anhui Prov, Hefei, Anhui, Peoples R China
5.Anhui Univ, Inst Informat Technol, Informat Mat & Intelligent Sensing Lab Anhui Prov, Hefei, Anhui, Peoples R China
6.Univ Sci & Technol China, Affiliated Hosp USTC 1, Div Life Sci & Med, Hefei, Anhui, Peoples R China
推荐引用方式
GB/T 7714
Gao, Yang,Chen, Bin,Wang, Ruru,et al. Knockdown of RRM1 in tumor cells promotes radio-/chemotherapy induced ferroptosis by regulating p53 ubiquitination and p21-GPX4 signaling axis[J]. CELL DEATH DISCOVERY,2022,8.
APA Gao, Yang.,Chen, Bin.,Wang, Ruru.,Xu, An.,Wu, Lijun.,...&Zhao, Guoping.(2022).Knockdown of RRM1 in tumor cells promotes radio-/chemotherapy induced ferroptosis by regulating p53 ubiquitination and p21-GPX4 signaling axis.CELL DEATH DISCOVERY,8.
MLA Gao, Yang,et al."Knockdown of RRM1 in tumor cells promotes radio-/chemotherapy induced ferroptosis by regulating p53 ubiquitination and p21-GPX4 signaling axis".CELL DEATH DISCOVERY 8(2022).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Gao, Yang]的文章
[Chen, Bin]的文章
[Wang, Ruru]的文章
百度学术
百度学术中相似的文章
[Gao, Yang]的文章
[Chen, Bin]的文章
[Wang, Ruru]的文章
必应学术
必应学术中相似的文章
[Gao, Yang]的文章
[Chen, Bin]的文章
[Wang, Ruru]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。